Top 10 Watch List: Pharma CEOs on the Rise
10/23/20 • 18 min
In this podcast we feature a list of the Top 10 pharma CEOs to watch in 2020. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers)
- Pharma CEOs to watch in 2020
- 1. Three-way tie: Pfizer, J&J, and AstraZeneca.
- Pfizer Chairman and CEO Albert Bourla
- J&J Chairman and CEO Alex Gorsky
- AstraZeneca CEO Pascal Soriot
- 4. Moderna CEO Stéphane Bancel
- 5. Gilead Sciences Chairman and CEO Daniel O’Day
- 6. Regeneron Pharmaceuticals Co-Founder, President and CEO Leonard S. Schleifer
- 7 (tie). CureVac CEO Franz-Werner Haas and Novavax CEO and President Stanley C. Erck
- 9. Seagen (formerly Seattle Genetics) President, CEO and Chairman Clay Siegall
- 10. Genmab CEO Jan G. J. van de Winkel
Sponsor: LabVantage Solutions
Links:
Subscribe to our e-newsletter at www.dcatvci.org
Follow us on Twitter @DCATvci
Support the show (https://dcat.org/MemberApplication.htm)
In this podcast we feature a list of the Top 10 pharma CEOs to watch in 2020. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers)
- Pharma CEOs to watch in 2020
- 1. Three-way tie: Pfizer, J&J, and AstraZeneca.
- Pfizer Chairman and CEO Albert Bourla
- J&J Chairman and CEO Alex Gorsky
- AstraZeneca CEO Pascal Soriot
- 4. Moderna CEO Stéphane Bancel
- 5. Gilead Sciences Chairman and CEO Daniel O’Day
- 6. Regeneron Pharmaceuticals Co-Founder, President and CEO Leonard S. Schleifer
- 7 (tie). CureVac CEO Franz-Werner Haas and Novavax CEO and President Stanley C. Erck
- 9. Seagen (formerly Seattle Genetics) President, CEO and Chairman Clay Siegall
- 10. Genmab CEO Jan G. J. van de Winkel
Sponsor: LabVantage Solutions
Links:
Subscribe to our e-newsletter at www.dcatvci.org
Follow us on Twitter @DCATvci
Support the show (https://dcat.org/MemberApplication.htm)
Previous Episode
The Pipeline Contenders: What Drugs Are Making the Mark?
In this podcast we feature an article that looks at some key upcoming developments from the pipelines of the large pharmaceutical companies for new drugs or existing drugs with new indications with blockbuster potential. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers)
- Inside Big Pharma’s pipeline
- AbbVie
- Amgen/AstraZeneca
- AstraZeneca
- Bristol-Myers Squibb
- Eli Lilly and Company
- GlaxoSmithKline
- Roche
Sponsor: Vetter Pharma International GmbH
Links:
Subscribe to our e-newsletter at www.dcatvci.org
Follow us on Twitter @DCATvci
Support the show (https://dcat.org/MemberApplication.htm)
Next Episode
Solid-Dosage Mfg: CDMO Market and Product Trends
In this podcast we feature an article that looks at solid dosage manufacturing in terms of CDMO growth rates and recent product trends. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers)
- New drug approvals and solid-dosage products
- CDMOs/CMOs: inside the numbers
- Recent facility acquisitions among solid-dose CDMOs/CMOs
- Other expansions
- Catalent
- Lonza
- Metrics Contract Services
- NextPharma
- Thermo Fisher Scientific
- LGM Pharma
- Frontida BioPharm
- Adare Pharmaceuticals
- CoreRx
- Velesco Pharma
- Upperton Pharma Solutions
Sponsor: Vetter Pharma International GmbH
Links:
Subscribe to our e-newsletter at www.dcatvci.org
Follow us on Twitter @DCATvci
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/dcat-value-chain-insights-production-to-prescription-649633/top-10-watch-list-pharma-ceos-on-the-rise-85679245"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to top 10 watch list: pharma ceos on the rise on goodpods" style="width: 225px" /> </a>
Copy